Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)
Authors
Keywords
-
Journal
Biomolecules
Volume 10, Issue 8, Pages 1171
Publisher
MDPI AG
Online
2020-08-12
DOI
10.3390/biom10081171
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system
- (2020) Susanne Pfefferle et al. Eurosurveillance
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of Critically Ill Adults With COVID-19
- (2020) Jason T. Poston et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
- (2020) Pavan K. Bhatraju et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19
- (2020) Stefan Kluge et al. Medizinische Klinik-Intensivmedizin und Notfallmedizin
- Adrenomedullin Induces Cardiac Lymphangiogenesis After Myocardial Infarction and Regulates Cardiac Edema Via Connexin 43
- (2019) Claire E. Trincot et al. CIRCULATION RESEARCH
- A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)
- (2019) Christopher Geven et al. BMJ Open
- Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics
- (2019) Benjamin Deniau et al. EUROPEAN JOURNAL OF HEART FAILURE
- Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial
- (2019) Koji Takagi et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dipeptidyl peptidase 3, a biomarker in cardiogenic shock and hopefully much more
- (2019) Aurora Magliocca et al. EUROPEAN JOURNAL OF HEART FAILURE
- Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects
- (2018) Christopher Geven et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Vascular Effects of Adrenomedullin and the Anti-Adrenomedullin Antibody Adrecizumab in Sepsis
- (2018) Christopher Geven et al. SHOCK
- Precursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarction
- (2018) Svenja Hinrichs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adrenomedullin in heart failure: pathophysiology and therapeutic application
- (2018) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock
- (2017) Heli Tolppanen et al. Annals of Intensive Care
- On Endogenous Angiotensin II Antagonism in Hypertension
- (2016) María Paz Ocaranza et al. HYPERTENSION
- World Medical Association Declaration of Helsinki
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adrenomedullin attenuates ventilator-induced lung injury in mice
- (2010) H. C. Muller et al. THORAX
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started